Cencora, Inc.
CORAPI behind this page
COR Q2 2026 request
Playground key active
/api/financials?ticker=COR&year=2026&quarter=2
Pick an endpoint and run the request.Income Statement
| Metric | Q2 2026 | Q2 2025 | YoY |
|---|---|---|---|
| Revenue (Q) | — | — | — |
Show Product Lines breakouts |
|||
| Alliance Healthcare · International Healthcare Solutions | 6,516,466 | 5,771,991 | +12.9% |
| Animal Health · Corporate Non Segment | 1,435,789 | 1,363,032 | +5.3% |
| Other Healthcare Solutions · International Healthcare Solutions | 1,049,283 | 924,788 | +13.5% |
| Other Non Strategic Businesses · Corporate Non Segment | 619,782 | 593,375 | +4.5% |
Show Business Segments breakouts |
|||
| International Healthcare Solutions · Operating Segments | 7,565,749 | 6,696,779 | +13.0% |
| US Healthcare Solutions · Operating Segments | 68,765,078 | 66,819,265 | +2.9% |
Show — breakouts |
|||
| Revenue | 78,355,916 | 75,453,673 | +3.8% |
Show Consolidation Items breakouts |
|||
| Corporate Non Segment | 2,055,571 | 1,956,407 | +5.1% |
| Intersegment Elimination | -30,482 | -18,778 | -62.3% |
| Cost of Revenue (Q) | — | — | — |
Show Business Segments breakouts |
|||
| International Healthcare Solutions · Operating Segments | 6,751,460 | 5,980,518 | +12.9% |
| US Healthcare Solutions · Operating Segments | 66,512,805 | 64,937,891 | +2.4% |
Show — breakouts |
|||
| Cost of Revenue | 74,767,577 | 72,393,864 | +3.3% |
Show Consolidation Items breakouts |
|||
| Corporate Non Segment | 1,743,941 | 1,638,025 | +6.5% |
| Intersegment Elimination | -26,214 | -17,872 | -46.7% |
| Operating Segments | 74,981,992 | 72,538,562 | +3.4% |
| Gross Profit (Q) | — | — | — |
Show — breakouts |
|||
| Gross Profit | 3,588,339 | 3,059,809 | +17.3% |
| Selling, General & Administrative (Q) | — | — | — |
Show — breakouts |
|||
| Selling, General & Administrative | 1,977,559 | 1,600,040 | +23.6% |
| Operating Expenses (Q) | — | — | — |
Show Business Segments breakouts |
|||
| International Healthcare Solutions · Operating Segments | 638,492 | 561,663 | +13.7% |
| US Healthcare Solutions · Operating Segments | 1,253,973 | 936,405 | +33.9% |
Show — breakouts |
|||
| Operating Expenses | 2,110,575 | 1,722,847 | +22.5% |
Show Consolidation Items breakouts |
|||
| Corporate Non Segment | 219,997 | 225,531 | -2.5% |
| Intersegment Elimination | -1,887 | -752 | -150.9% |
| Operating Income (Q) | — | — | — |
Show Business Segments breakouts |
|||
| International Healthcare Solutions · Operating Segments | 175,797 | 154,598 | +13.7% |
| US Healthcare Solutions · Operating Segments | 998,300 | 944,969 | +5.6% |
Show — breakouts |
|||
| Operating Income | 1,142,593 | 1,036,190 | +10.3% |
Show Consolidation Items breakouts |
|||
| Corporate Non Segment | 91,633 | 92,851 | -1.3% |
| Intersegment Elimination | -2,381 | -154 | -1446.1% |
| Operating Segments | 1,263,349 | 1,192,264 | +6.0% |
| Non-Operating Income (Expense) (Q) | — | — | — |
Show — breakouts |
|||
| Non-Operating Income (Expense) | 1,086,439 | -3,546 | +30738.4% |
| Income Before Taxes (Q) | — | — | — |
Show — breakouts |
|||
| Income Before Taxes | 2,088,572 | 928,656 | +124.9% |
| Income Tax Expense (Benefit) (Q) | — | — | — |
Show — breakouts |
|||
| Income Tax Expense (Benefit) | 459,044 | 211,239 | +117.3% |
| Net Income (Q) | — | — | — |
Show — breakouts |
|||
| Net Income | 1,641,332 | 717,871 | +128.6% |
| Net Income (Q) | — | — | — |
Show Equity Components breakouts |
|||
| Noncontrolling Interest | -11,804 | -454 | -2500.0% |
| Retained Earnings | 1,641,332 | 717,871 | +128.6% |
Show — breakouts |
|||
| Net Income | 1,629,528 | 717,417 | +127.1% |
| Comprehensive Income (Q) | — | — | — |
Show — breakouts |
|||
| Comprehensive Income | 1,585,102 | 915,657 | +73.1% |
| EPS (Basic) (Q) | — | — | — |
Show — breakouts |
|||
| EPS (Basic) | 8.44 | 3.7 | +128.1% |
| EPS (Diluted) (Q) | — | — | — |
Show — breakouts |
|||
| EPS (Diluted) | 8.4 | 3.68 | +128.3% |
| Wtd Avg Shares (Basic) (Q) | — | — | — |
Show — breakouts |
|||
| Wtd Avg Shares (Basic) | 194,545 | 193,796 | +0.4% |
| Wtd Avg Shares (Diluted) (Q) | — | — | — |
Show — breakouts |
|||
| Wtd Avg Shares (Diluted) | 195,383 | 195,094 | +0.1% |
| Net Income Loss Attributable To Noncontrolling Interest (Q) | — | — | — |
Show — breakouts |
|||
| Net Income Loss Attributable To Noncontrolling Interest | -11,804 | -454 | -2500.0% |
Balance Sheet
| Metric | Q2 2026 | Q2 2025 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents (Q) | — | — | — |
Show — breakouts |
|||
| Cash & Cash Equivalents | 2,176,496 | 1,978,061 | +10.0% |
| Accounts Receivable (Q) | — | — | — |
Show — breakouts |
|||
| Accounts Receivable | 24,893,220 | 23,715,008 | +5.0% |
| Inventory (Q) | — | — | — |
Show — breakouts |
|||
| Inventory | 20,010,006 | 18,965,502 | +5.5% |
Show Consolidated Entities breakouts |
|||
| Variable Interest Entity Primary Beneficiary | 284,941 | 266,783 | +6.8% |
| Prepaid Expenses & Other Current Assets (Q) | — | — | — |
Show — breakouts |
|||
| Prepaid Expenses & Other Current Assets | 636,815 | 574,871 | +10.8% |
| Total Current Assets (Q) | — | — | — |
Show — breakouts |
|||
| Total Current Assets | 53,140,911 | 46,534,973 | +14.2% |
| Non-Current Assets | |||
| Property, Plant & Equipment (Q) | — | — | — |
Show — breakouts |
|||
| Property, Plant & Equipment | 2,805,419 | 2,302,809 | +21.8% |
Show Consolidated Entities breakouts |
|||
| Variable Interest Entity Primary Beneficiary | 77,182 | 54,317 | +42.1% |
| Goodwill (Q) | — | — | — |
Show Business Segments breakouts |
|||
| International Healthcare Solutions · Operating Segments | 2,613,296 | — | — |
| US Healthcare Solutions · Operating Segments | 13,839,373 | — | — |
Show — breakouts |
|||
| Goodwill | 16,452,669 | 14,091,412 | +16.8% |
| Intangible Assets (Q) | — | — | — |
Show Finite Lived Intangible Assets By Major Class breakouts |
|||
| Customer Relationships | 2,683,551 | 3,392,058 | -20.9% |
| Other Intangible Assets | 3,354,165 | — | — |
| Deferred Tax Assets (Q) | — | — | — |
Show — breakouts |
|||
| Deferred Tax Assets | 192,825 | 233,700 | -17.5% |
| Other Non-Current Assets (Q) | — | — | — |
Show — breakouts |
|||
| Other Non-Current Assets | 3,005,560 | 4,168,145 | -27.9% |
Show Consolidated Entities breakouts |
|||
| Variable Interest Entity Primary Beneficiary | 108,359 | 90,115 | +20.2% |
| Total Assets (Q) | — | — | — |
Show — breakouts |
|||
| Total Assets | 81,652,100 | 71,193,874 | +14.7% |
Show Consolidated Entities breakouts |
|||
| Variable Interest Entity Primary Beneficiary | 895,898 | 785,433 | +14.1% |
| Current Liabilities | |||
| Accounts Payable (Q) | — | — | — |
Show — breakouts |
|||
| Accounts Payable | 51,881,816 | 50,110,563 | +3.5% |
| Accrued Liabilities (Q) | — | — | — |
Show — breakouts |
|||
| Accrued Liabilities | 3,195,861 | 2,447,498 | +30.6% |
| Current Portion of Long-Term Debt (Q) | — | — | — |
Show Debt Instrument breakouts |
|||
| Alliance Healthcare Debt | 48,643 | 7,125 | +582.7% |
| Multi Currency Revolving Credit Facility | 28,744 | 708,000 | -95.9% |
| Nonrecourse Debt | 77,772 | 55,196 | +40.9% |
| One Oncology Physicians Notes | 47,501 | — | — |
| Total Current Liabilities (Q) | — | — | — |
Show — breakouts |
|||
| Total Current Liabilities | 56,132,286 | 53,328,382 | +5.3% |
| Debt Current (Q) | — | — | — |
Show — breakouts |
|||
| Debt Current | 202,660 | 770,321 | -73.7% |
| Non-Current Liabilities | |||
| Long-Term Debt (Q) | — | — | — |
Show Debt Instrument breakouts |
|||
| A10000002.700 Senior Notes Due2031 | 994,398 | 993,278 | +0.1% |
| A10000004.900 Senior Notes Due2036 | 989,677 | — | — |
| A5000002.800 Senior Notes Due2030 | 497,480 | 496,870 | +0.1% |
| A5000002.875 Senior Notes Due2028 | 572,378 | — | — |
| A5000003.625 Senior Notes Due2032 | 570,009 | — | — |
| A5000003.950 Senior Notes Due2029 | 496,984 | — | — |
| A5000004.250 Senior Notes Due2030 | 496,108 | — | — |
| A5000004.250 Senior Notes Due2045 | 495,901 | 495,685 | 0.0% |
| A5000004.300 Senior Notes Due2047 | 494,221 | 493,954 | +0.1% |
| A5000004.600 Senior Notes Due2033 | 496,502 | — | — |
| A5000004.625 Senior Notes Due2027 | 497,921 | 496,696 | +0.2% |
| A5000005.125 Senior Notes Due2034 | 495,398 | 494,810 | +0.1% |
| A5000005.650 Senior Notes Due2056 | 491,643 | — | — |
| A6000004.850 Senior Notes Due2029 | 597,006 | 596,199 | +0.1% |
| A7000005.150 Senior Notes Due2035 | 695,186 | 694,633 | +0.1% |
| A7500003.450 Senior Notes Due2027 | 748,570 | 747,728 | +0.1% |
| Alliance Healthcare Debt | 48,643 | 7,125 | +582.7% |
| Multi Currency Revolving Credit Facility | 28,744 | 708,000 | -95.9% |
| Nonrecourse Debt | 200,341 | 132,276 | +51.5% |
| One Oncology Physicians Notes | 380,404 | — | — |
| Term Loan Facility Due In2027 | 799,300 | 1,498,953 | -46.7% |
| Term Loan Facility Due In2028 | 299,630 | — | — |
| Term Loan Facility Due In2029 | 999,076 | — | — |
Show — breakouts |
|||
| Long-Term Debt | 12,385,520 | 7,856,207 | +57.7% |
Show Consolidated Entities breakouts |
|||
| Variable Interest Entity Primary Beneficiary | 122,569 | 77,080 | +59.0% |
| Long-Term Debt (Q) | — | — | — |
Show — breakouts |
|||
| Long-Term Debt | 12,182,860 | 7,085,886 | +71.9% |
| Deferred Tax Liabilities (Q) | — | — | — |
Show — breakouts |
|||
| Deferred Tax Liabilities | 1,748,178 | 1,615,752 | +8.2% |
Show Consolidated Entities breakouts |
|||
| Variable Interest Entity Primary Beneficiary | 7,977 | 15,545 | -48.7% |
| Other Non-Current Liabilities (Q) | — | — | — |
Show — breakouts |
|||
| Other Non-Current Liabilities | 3,794,575 | 3,421,715 | +10.9% |
Show Consolidated Entities breakouts |
|||
| Variable Interest Entity Primary Beneficiary | 82,910 | 66,577 | +24.5% |
| Total Liabilities (Q) | — | — | — |
Show Consolidated Entities breakouts |
|||
| Variable Interest Entity Primary Beneficiary | 681,895 | 591,196 | +15.3% |
| Accrued Income Taxes Noncurrent (Q) | — | — | — |
Show — breakouts |
|||
| Accrued Income Taxes Noncurrent | 352,768 | 277,738 | +27.0% |
| Stockholders' Equity | |||
| Common Stock (Q) | — | — | — |
Show — breakouts |
|||
| Common Stock | 2,983 | 2,972 | +0.4% |
| Retained Earnings (Q) | — | — | — |
Show — breakouts |
|||
| Retained Earnings | 8,491,234 | 6,401,534 | +32.6% |
| Accumulated Other Comprehensive Income (Q) | — | — | — |
Show — breakouts |
|||
| Accumulated Other Comprehensive Income | -961,308 | -1,201,838 | +20.0% |
| Total Stockholders' Equity (Q) | — | — | — |
Show — breakouts |
|||
| Total Stockholders' Equity | 3,397,590 | 1,012,837 | +235.5% |
| Total Liabilities & Equity (Q) | — | — | — |
Show — breakouts |
|||
| Total Liabilities & Equity | 81,652,100 | 71,193,874 | +14.7% |
Cash Flow Statement
| Metric | YTD Q2 2026 | YTD Q2 2025 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Depreciation & Amortization (YTD) | — | — | — |
Show Business Segments breakouts |
|||
| International Healthcare Solutions · Operating Segments | 72,744 | 64,459 | +12.9% |
| US Healthcare Solutions · Operating Segments | 166,246 | 133,061 | +24.9% |
Show — breakouts |
|||
| Depreciation & Amortization | 509,693 | 538,310 | -5.3% |
Show Consolidation Items breakouts |
|||
| Corporate Non Segment | 29,269 | 38,923 | -24.8% |
| Stock-Based Compensation (YTD) | — | — | — |
Show — breakouts |
|||
| Stock-Based Compensation | 94,056 | 98,836 | -4.8% |
| Deferred Income Taxes (YTD) | — | — | — |
Show — breakouts |
|||
| Deferred Income Taxes | 192,769 | 21,133 | +812.2% |
| Other Non-Cash Items (YTD) | — | — | — |
Show — breakouts |
|||
| Other Non-Cash Items | -1,045 | -9,814 | +89.4% |
| Change in Accounts Receivable (YTD) | — | — | — |
Show — breakouts |
|||
| Change in Accounts Receivable | 308,675 | 218,043 | +41.6% |
| Change in Inventory (YTD) | — | — | — |
Show — breakouts |
|||
| Change in Inventory | 120,202 | -34,252 | +450.9% |
| Change in Accounts Payable (YTD) | — | — | — |
Show — breakouts |
|||
| Change in Accounts Payable | -2,193,885 | -669,479 | -227.7% |
| Change in Prepaid & Other Assets (YTD) | — | — | — |
Show — breakouts |
|||
| Change in Prepaid & Other Assets | -54,104 | -94,273 | +42.6% |
| Net Cash from Operations (YTD) | — | — | — |
Show — breakouts |
|||
| Net Cash from Operations | -966,530 | 632,456 | -252.8% |
| Investing Activities | |||
| Capital Expenditures (YTD) | — | — | — |
Show — breakouts |
|||
| Capital Expenditures | 284,994 | 234,953 | +21.3% |
| Other Investing Activities (YTD) | — | — | — |
Show — breakouts |
|||
| Other Investing Activities | 2,376 | 10,558 | -77.5% |
| Net Cash from Investing (YTD) | — | — | — |
Show — breakouts |
|||
| Net Cash from Investing | -5,174,216 | -4,420,662 | -17.0% |
| Financing Activities | |||
| Tax Withholding for Share Compensation (YTD) | — | — | — |
Show — breakouts |
|||
| Tax Withholding for Share Compensation | 105,186 | 77,558 | +35.6% |
| Net Cash from Financing (YTD) | — | — | — |
Show — breakouts |
|||
| Net Cash from Financing | 4,021,771 | 2,717,412 | +48.0% |
| Other Cash Flow | |||
| Net Change in Cash (YTD) | — | — | — |
Show — breakouts |
|||
| Net Change in Cash | -2,158,287 | -1,119,314 | -92.8% |
Values in thousands USD. Source: SEC EDGAR 10-Q filing.